Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance
Clinical Microbiology and Infection · 2026-07
DOI: 10.1016/j.cmi.2026.06.030 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Microbiology and Infection, 2026-07. Verfasst von Moubadda Assi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Balamand, Beirut, Lebanon. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Health Sciences, University of Balamand, Beirut, Lebanon.
- School of Medicine, Lebanese American University, Beirut, Lebanon. Electronic address: ismaelmaatouk@gmail.com.
Zitieren
APA
Assi, M., & Maatouk, I. (2026). Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.06.030
Vancouver
Assi M, Maatouk I. Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.06.030
BibTeX
@article{Assi2026,
author = {Assi, Moubadda and Maatouk, Ismaël},
title = {Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance},
journal = {Clinical Microbiology and Infection},
year = {2026},
doi = {10.1016/j.cmi.2026.06.030}
}
EUVIMED